Equity Overview
Price & Market Data
Price: $0.0841
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $3,014,463
Volume: 0
Performance Metrics
1 Week: -28.73%
1 Month: -46.09%
3 Months: -73.30%
6 Months: -54.29%
1 Year: -68.84%
YTD: -71.13%
Company Details
Employees: 5
Sector: Technology services
Industry: Packaged software
Country: United States
Details
FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in Minneapolis, Minnesota.